Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant Recipients

BACKGROUND: Kidney transplant recipients (KTRs) receiving the mammalian target of rapamycin inhibitor sirolimus may display a reduced risk of skin cancer development compared to KTRs receiving calcineurin inhibitors. Despite studies investigating the effects of these 2 drug classes on T cells in pat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transplant Direct
Asıl Yazarlar: Burke, Michael Thomas, Sambira Nahum, Lauren C., Isbel, Nicole M., Carroll, Robert P., Soyer, Hans Peter, Francis, Ross, Bridge, Jennifer Anne, Hawley, Carmel, Oliver, Kimberly, Staatz, Christine E., Wells, James William
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2017
Konular:
Kidney Transplantation
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5498012/
https://ncbi.nlm.nih.gov/pubmed/28706974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000694
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller